Avara Pharmaceutical Services

Avara Pharmaceutical Services

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Avara is an established pharmaceutical contract manufacturing organization (CMO) with a global footprint, founded in 1999 and headquartered in Norman, Oklahoma. The company's core capabilities include oral solid dose (OSD) manufacturing, sterile fill-finish for liquids and lyophilized products, and integrated packaging, with a strong emphasis on handling potent compounds and meeting international regulatory standards. It operates former large-scale facilities from major pharma companies (Merck, Pfizer, Astellas), leveraging their legacy expertise to serve over 40 countries. As a private service provider, Avara's business model is built on long-term client partnerships and flexible, tailored manufacturing solutions.

Drug DeliverySmall Molecules

Technology Platform

Integrated contract manufacturing platform for oral solid dose (including potent compounds), sterile fill-finish (liquid & lyophilized), and integrated packaging services. Utilizes legacy facilities from major pharma with global regulatory approvals.

Opportunities

Growth in outsourcing of complex manufacturing, especially for potent compounds and sterile injectables, presents a significant opportunity.
Avara's global regulatory approvals and former Big Pharma facilities position it to capture contracts from companies seeking low-risk, established manufacturing partners for global supply.

Risk Factors

Key risks include operational/regulatory failure at a facility impacting multiple clients, high competition in the CMO sector pressuring pricing, and dependence on the health and trends of the broader pharmaceutical R&D pipeline.
Client concentration is also a potential risk.

Competitive Landscape

Avara competes in the fragmented pharmaceutical CMO market against large global players (e.g., Lonza, Catalent, Thermo Fisher) and numerous specialized mid-sized and regional manufacturers. Its differentiation lies in its focus on legacy, proven facilities, handling of potent compounds, and a client-flexible approach within the oral solid dose and sterile fill-finish niches.